Petra Zieglmayer

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

Friedrich Horak, Petra Zieglmayer, René Zieglmayer et al. · Journal of Allergy and Clinical Immunology · 2009 · 174 citations

Asthma, Allergy, Early Onset +9

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

Hendrik Nolte, Jennifer Maloney, Harold S. Nelson et al. · Journal of Allergy and Clinical Immunology · 2015 · 158 citations

Environmental Allergy, House Dust, Allergy +13

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy

Petra Zieglmayer, Margarete Focke‐Tejkl, René Schmutz et al. · EBioMedicine · 2016 · 136 citations · Full text

The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber

Friedrich Horak, Petra Zieglmayer, René Zieglmayer et al. · Inflammation Research · 2009 · 85 citations

Asthma, Vienna Challenge Chamber, Allergen-induced Nasal +9

The <scp>CRTH</scp>2 antagonist <scp>OC</scp>000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo‐controlled, double‐blind trial

Friedrich Horak, Petra Zieglmayer, René Zieglmayer et al. · Allergy · 2012 · 84 citations